Table 4.
r value | p value | |
---|---|---|
All participants | ||
sRAGE vs. CML | 0.60 | 0.001 |
sRAGE vs. 25-hydroxy-vitamin D | 0.65 | 0.0004 |
sRAGE vs. insulin | −0.18 | 0.4 |
PCOS group | ||
sRAGE vs. CML | −0.37 | 0.2 |
sRAGE vs. 25-hydroxy-vitamin D | 0.75 | 0.007 |
sRAGE vs. insulin | −0.10 | 0.7 |
Control group | ||
sRAGE vs. CML | 0.89 | 0.0001 |
sRAGE vs. 25-hydroxy-vitamin D | 0.72 | 0.007 |
sRAGE vs. insulin | −0.11 | 0.7 |
sRAGE soluble receptors for advanced glycation end products, CML N-(carboxymethyl) lysine